Erythropoietin Falls Short of Neuroprotection in Optic Neuritis ...Middle East

A higher rate of conversion to multiple sclerosis in the placebo group offered a glimmer of hope for treatment in TONE, a phase 3 randomized trial, but caveats loom large. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Erythropoietin Falls Short of Neuroprotection in Optic Neuritis )

Also on site :

• Beloved ‘Days of our Lives’ Star Breaks Silence After Emmy Snub
• Mike Levin: 10 big steps to help us get back to common sense and common ground
• Trump threatens 35% tariff on Canadian goods and says he may double what other nations are charged